You are here: Industry Insights > AstraZeneca

News List

Japan has pre-ordered COVID-19 vaccine doses for more than four times its population, says report europeanpharmaceuticalreview
January 20, 2021
Japan has procurement deals with half of the companies leading the COVID-19 vaccine development race, according to GlobalData.
Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer pharmaceutical-business-review
January 20, 2021
New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience.
AZ, Daiichi Sankyo’s Enhertu wins US approval for HER2-positive gastric cancer pharmatimes
January 19, 2021
AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval in the US for the treatment of locally advanced/metastatic HER2-positive gastric or gastroesophageal junction (GEJ) ...
SII expects WHO emergency nod for AstraZeneca – Oxford University vaccine soon expresspharma
January 15, 2021
Poonawalla also said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April.
Farxiga Granted Priority Review in US for Chronic Kidney Disease americanpharmaceuticalreview
January 14, 2021
AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).
EMA receives authorisation application for AstraZeneca COVID-19 vaccine europeanpharmaceuticalreview
January 13, 2021
The EMA has received a conditional marketing authorisation application for the Oxford-AstraZeneca COVID-19 vaccine.
Tezepelumab Trial Does Not Meet Primary Endpoint americanpharmaceuticalreview
January 08, 2021
Amgen and AstraZeneca announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid (OCS) dose, without loss of asthma control, with tezepelumab compared to placebo.
AstraZeneca applies for emergency use for vaccine in Philippines expresspharma
January 07, 2021
AstraZeneca has applied to health regulators for emergency use authorisation (EUA) of its COVID-19 vaccine in the Philppines, the food and drugs agency chief said on Wednesday.
AstraZeneca divests Atacand commercial rights to Cheplapharm pharmaceutical-technology.
January 06, 2021
AstraZeneca has completed the divestment of commercial rights to Atacand (candesartan cilexetil) and Atacand Plus in over 70 countries to German pharmaceutical firm Cheplapharm Arzneimittel.
UK approves AstraZeneca’s Covid-19 vaccine for emergency use pharmaceutical-technology
January 04, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorisation for emergency supply to AstraZeneca’s Covid-19 vaccine in the country.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page